Author:
Shen Xue-Bin,Ding Da-Li,Yu Li-Zhen,Ni Jin-Zhong,Liu Yao,Wang Wei,Liu Li-Min,Nian Si-Hui
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference37 articles.
1. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis;Fernandez;Lancet,2012
2. Idiopathic pulmonary fibrosis: pathogenesis and management;Sgalla;Respir. Res.,2018
3. Lung transplantation for idiopathic pulmonary fibrosis;George;Lancet Respir. Med.,2019
4. Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial;Richeldi;Lancet Respir. Med.,2020
5. Nintedanib for idiopathic pulmonary fibrosis;Tepede;J. Pharm. Pract.,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献